Visit Illinois Cannabis Page
Visit Illinois Cannabis Page – On August 12, 2019, changes to the Compassionate Use of Medical Cannabis Program became effective. The Compassionate Use of Medical Cannabis Program Act is a permanent program and the “pilot” designation has been removed. While some provisions will become effective immediately, there is significant work the Illinois Department of Public Health (IDPH) must complete before all the changes can be implemented. Some of the requirements affect other state programs, databases and IT systems and these changes will require additional time to ensure they are completed correctly. We have added a new page to our website that provides the essentials of the Illinois Medical and Adult-Use Cannabis statutes. Watch that page, as our coverage may expand if our friends and clients demonstrate a demand for our services. You can access the page by clicking on the IDPH logo.
The information below explains the changes to the Medical Cannabis Patient Program (MCPP) and the Opioid Alternative Pilot Program (OAPP) and the proposed start dates.
The Illinois Dept. of Public Health [Main Page of Medical Cannabis Program] added Neuropathy to its list of qualifying conditions among others in a new piece of legislation that went live on August 12, 2019. The program now has classifications for terminal illnesses, opioid alternatives, medical, and soon to be adult-use cannabis. There are also special categories for caregivers, minors and veterans.
Visit Illinois Cannabis Page
Changes brought by new legislation include:
Qualifying patients will receive provisional registration allowing them to purchase medical marijuana for 90 days while their application is being processed (or until it is denied).
Criminal background checks and fingerprint requirements will be eliminated for all participants/applicants in the existing MMJ program and the new Opioid Alternative Pilot Program
MMJ qualifying conditions added are chronic pain, anorexia nervosa, irritable bowel syndrome, migraines, osteoarthritis, anorexia nervosa, Ehlers-Danlos syndrome, Neuro-Behcet’s autoimmune disease, neuropathy, polycystic kidney disease and superior canal dehiscence syndrome. Chronic pain tends to be the leading driver for MMJ sales.
Nurse practitioners and physician’s assistants, like doctors, now can certify patients for the program. [This is groundbreaking for MMJ programs]
The expansion gives added heft to a program that was bolstered substantially in late January when an opioid alternative pilot program kicked in. Former Republican Gov. Bruce Rauner signed that legislation.
The state’s MMJ program is that there is only a 1% sales tax.
Buyers of adult-use cannabis products, on the other hand, can expect to pay a retail tax of 19.55%-34.75%, depending on the product’s potency, according to the Marijuana Policy Project.